Who is eligible for the Progestin-Only Pill (POP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Who Can Take Progestin-Only Pills (POP)

Progestin-only pills (POPs) are suitable for most women, including those with contraindications to estrogen-containing contraceptives, as they have fewer restrictions and a more favorable safety profile compared to combined hormonal contraceptives. 1

Eligible Populations

Age Groups

  • POPs are safe for women of all ages, from menarche through menopause (Category 1) 1
  • Particularly suitable for women over 35 years who smoke, as they don't carry the cardiovascular risks associated with combined hormonal contraceptives 1

Reproductive Status

  • Safe for nulliparous women (Category 1) 1
  • Appropriate for parous women (Category 1) 1
  • Can be used by breastfeeding women as early as immediately postpartum (Category 2 if <1 month postpartum, Category 1 if ≥1 month postpartum) 1, 2
  • Can be used by non-breastfeeding women immediately postpartum (Category 1) 1

Medical Conditions Where POPs Are Particularly Beneficial

  • Women with history of venous thromboembolism (VTE) or risk factors for VTE (Category 2) 1, 3
  • Women with hypertension (Category 1 for controlled hypertension; Category 2 for severe hypertension) 1
  • Women with obesity (Category 1, regardless of BMI) 1
  • Women with migraine with or without aura (safer than combined hormonal methods) 1, 4
  • Smokers of any age and smoking intensity (Category 1) 1

Special Populations

Postpartum Women

  • Safe for immediate use in non-breastfeeding women postpartum (Category 1) 1, 5
  • For breastfeeding women <1 month postpartum (Category 2) - benefits generally outweigh risks 1, 2
  • For breastfeeding women ≥1 month postpartum (Category 1) - no restrictions 1, 2

Post-Abortion

  • Can be started immediately after abortion (first or second trimester) (Category 1) 1
  • Can be started immediately after septic abortion (Category 1) 1

Women with Cardiovascular Risk Factors

  • Women with multiple cardiovascular risk factors (Category 2) 1
  • Women with adequately controlled hypertension (Category 1) 1
  • Women with elevated blood pressure (systolic 140-159 mmHg or diastolic 90-99 mmHg) (Category 1) 1
  • Women with severe hypertension (systolic ≥160 mmHg or diastolic ≥100 mmHg) (Category 2) 1

Considerations and Limitations

Effectiveness Considerations

  • Requires strict adherence to timing (must be taken at the same time each day) for maximum effectiveness 1, 4
  • Higher typical use failure rate (9%) compared to long-acting reversible contraceptives (<1%) 2, 6

Medical History Considerations

  • Women with history of ectopic pregnancy (Category 2) - can use POPs but should be counseled about slightly increased risk 1
  • Women who have had bariatric surgery with malabsorptive procedures (Category 3) - may have reduced effectiveness 1

Timing of Initiation

  • Can be started at any time if reasonably certain the woman is not pregnant 1, 4
  • If started within first 5 days of menstrual cycle, no backup contraception needed 1, 4
  • If started >5 days since menstrual bleeding began, backup contraception needed for 2 days 1, 4
  • For postpartum women who are not breastfeeding, can start immediately (Category 1) 1, 5
  • For breastfeeding women, can start immediately postpartum (Category 2 if <1 month, Category 1 if ≥1 month) 1, 2

Common Pitfalls and Caveats

  • POPs must be taken at the same time each day (within a 3-hour window) for optimal effectiveness 1, 4
  • Irregular bleeding patterns are common and a leading cause of discontinuation - proper counseling about this side effect can improve adherence 4, 6
  • Despite being appropriate for many women, POPs are underutilized in the United States (only 0.4% of reproductive-aged women) 6
  • Women taking medications that induce liver enzymes may experience reduced contraceptive effectiveness 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Contraception Options for Breastfeeding Mothers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Contraceptive Management for Women Who Are at High Risk of Thrombosis.

Clinical obstetrics and gynecology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.